Back to Journals » International Medical Case Reports Journal » Volume 14

Sub-Tenon Injection of Triamcinolone Acetonide for Choroidal Mass in Sarcoidosis: A Case Report

Authors Kita M, Kagitani Y, Hama S, Azumi A

Received 27 November 2020

Accepted for publication 31 December 2020

Published 29 January 2021 Volume 2021:14 Pages 33—38


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Scott Fraser

Mihori Kita,1 Yu Kagitani,1 Sachiyo Hama,1 Atsushi Azumi2

1Department of Ophthalmology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan; 2Department of Ophthalmology, Kobe Kaisei Hospital, Kobe, Japan

Correspondence: Mihori Kita
Department of Ophthalmology, National Hospital Organization Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto-city, Kyoto 612-8555, Japan
Tel +81-75-641-9161
Fax +81-75-643-4325

Purpose: To report the clinical course of a sub-tenon injection of triamcinolone acetonide for treatment of an asymptomatic choroidal mass in sarcoidosis.
Methods: This was a retrospective, non-comparative interventional case study.
Results: A 36-year-old Japanese man with sarcoidosis presented with an asymptomatic choroidal mass lesion associated with subretinal fluid accumulation in his left eye, but without any other sign of intraocular inflammation in either of his eyes. He had started systemic steroid administration for thrombocytopenia 2 days prior to being examined. After a single sub-tenon injection of triamcinolone acetonide (20 mg) the subretinal fluid was completely absorbed and the choroidal granuloma began to shrink in size. After the injection, the granuloma became a scar without any complication or recurrence over the next 34 months.
Conclusion: Sub-tenon injection of triamcinolone acetonide might be an effective treatment for choroidal granuloma in sarcoidosis.

Keywords: sarcoidosis, choroidal mass, choroidal granuloma, sub-tenon injection, triamcinolone acetonide, steroid

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]